期刊文献+

VHL和CD31-MVD在结肠癌组织中的表达及临床意义 被引量:4

Expression and clinical significance of VHL and CD31-MVD in colon cancer
下载PDF
导出
摘要 目的:通过检测VHL和CD31标记的微血管密度(CD31-MVD)在结肠癌组织中的表达,探讨两者与结肠癌临床病理特征的相关性,从而了解VHL调控结肠癌发生发展的作用和机制。方法:收集结肠癌手术标本106例作为实验对象,应用免疫组化SP法检测VHL及CD31在结肠癌中的表达,分析VHL表达及CD31-MVD与患者临床病理特征之间的关系并分析二者相关性。结果:VHL在癌组织中的表达阳性率(46.2%)明显低于切缘正常组织(71.7%)(P<0.05)。VHL在结肠癌中的表达,与有无淋巴结转移、TNM分期相关(P<0.05),CD31-MVD在结肠癌中平均值24.50±4.54,与肿瘤最大径、有无淋巴结转移、TNM分期相关(P<0.05),与其他临床病理特征无关,且CD31-MVD与VHL的表达呈负相关。结论:VHL蛋白在结肠癌中呈低表达并和肿瘤转移、分期相关,VHL的表达缺失与结肠癌血管密度相关,并且可能通过调控血管生成影响结肠癌的生长及转移。 Objective:To study the VHL expression and density of microvessels indicated by CD31(CD31-MVD)in colon cancer and to explore the mechanisms of VHL in modulating the occurrence and development of colon cancer.Methods:The expression of VHL,CD31-MVD in colon cancer was evaluated by immunohistochemistry.The correlation of VHL and CD31 with clinico-pathological characteristics was analyzed.Results:VHL in cancer was significantly lower than that in normal control tissue(P<0.05).The expression of VHL was correlated with lymph node metastasis and TNM stage(P<0.05).The CD31-MVD was correlated with tumor size,lymph node metastasis and TNM stage(P<0.05).There was a negative correlation between VHL and CD31-MVD.Conclusion:VHL might play a critical role in tumor growth and invasion via angiogenesis in colon cancer.
作者 张舒 张君娜 蔡静 崔纪丽 张云鹤 孟珊珊 金家岩 Zhang Shu;Zhang Junna;Cai Jing;Cui Jili;Zhang Yunhe;Meng Shanshan;Jin Jiayan(Department of Pathology,the First Affiliated Hospital of Henan University,Henan Kaifeng 475001,China)
出处 《现代肿瘤医学》 CAS 2020年第13期2264-2267,共4页 Journal of Modern Oncology
基金 开封市科技发展计划项目(编号:1808011)。
关键词 结肠癌 VHL CD31 血管生成 转移 colon caner VHL CD31 angiogenesis metastasis
  • 相关文献

参考文献3

二级参考文献49

  • 1Sevim A,Ismet Y,Hakan V,et al.Genetic evaluation of von Hippel-Lindau disease for early diagnosis and improved prognosis.Int Urol Nephrol,2008,40:615-620.
  • 2Melanie GH,Rosanne G,Paul K,et al.Von Hippel-Lindau disease in pregnancy:a brief review.J Clin Neurosci,2009,16:611-613.
  • 3Latif F,Tory K,Gnarra J,et al.Identification of the von Hippel-Lindau disease tumor suppressor gene.Science,1993,260:1317-1320.
  • 4Patard JJ,Leray E,Rioux-Leclercq N,et al.Prognostic value of histologic subtypes in renal cell carcinoma:a multicenter experience.Clin Oncol,2005,23:63-71.
  • 5Kuzmin I,Duh FM,Latif F,et al.Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.Oncogene,1995,10:2185-2194.
  • 6Blankenship C,Nagl JG,Whaley JM,et al.Alternate choice of initiation coden produces a biologically active product of the von-Hippel Lindan gene with tumor or suppressor activity.Oncogene,1999,18:1529-1535.
  • 7Kim W,Kaelin WG.The von Hippel-Lindau tumor suppressor protein:new insights into oxygen sensing and cancer.Curr Opin Genet Dev,2003,13:55-60.
  • 8Berndt JD,Moon RT,et al.β-catenin gets jaded and von Hippel-Lindau is to blame.Trends in Biochemical Sciences,2009,34:101-104.
  • 9Zhou MI,Foy RL,et al.Jade-1,a candidate renal tumor suppressor that promotes apoptosis.Proc Natl Acad Sci USA,2005,102:11035-11040.
  • 10Vipul CC,Rebecca L,et al.Jade-1 inhibits Wnt signalling by ubiquitylating β-catenin and mediates Wnt pathway inhibition by pVHL.Nature Cell Biology,2008,10:1208-1216.

共引文献11

同被引文献63

引证文献4

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部